Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01815775
Other study ID # PI05-PR-LEGARS
Secondary ID 2006/0023
Status Completed
Phase Phase 0
First received March 19, 2013
Last updated March 19, 2013
Start date March 2006
Est. completion date July 2009

Study information

Verified date March 2013
Source Centre Hospitalier Universitaire, Amiens
Contact n/a
Is FDA regulated No
Health authority France: DGS - Delegation générale de la Santé
Study type Interventional

Clinical Trial Summary

The idea is to assess the predictive value of flow magnetic resonance imaging (flow MRI) for patient suffering normal pressure hydrocephalus (NPH) planned for surgery. By now, the depletive lumbar puncture is the best test assessing the efficacy of a forthcoming surgery. The idea is to demonstrate that flow MRI can be as effective as lumbar puncture in term of predictive value of surgery response.

In that way, cerebrospinal fluid (CSF) dynamics are evaluated by a single non invasive examination. CSF flow is measured at the Sylvius' aqueduct, cervical, arachnoid space and 4th ventricle levels.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 2009
Est. primary completion date July 2008
Accepts healthy volunteers No
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- age: over 20 years

- diagnostic of normal pressure hydrocephalus

- ventricular dilation visible on radiological examination

- patients gave their written informed consent

Exclusion Criteria:

- age: less than 20 years

- MRI contra-indication

- pregnancy

- lumbar puncture within 48 hours before MRI

- cardiac arrhythmia

- cerebral/lacunar stroke

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label


Intervention

Other:
clinical and imaging examinations
Quantitative CSF flow study was performed by 2D phase-contrast velocity-encoded cine MRI (repetition/echo time, 15/7 ms; field of view = 140 x 140 mm²; matrix size = 256 x 128, flip angle = 25 degrees,one excitation, slice thickness = 5 mm). Cerebrospinal fluid flow was measured with a velocity-encoding value of 10-20 cm/s. Peripheral gating was used to cover the entire cardiac cycle with retrospective cardiac synchronization of 32 quantitative flow-encoded images per cycle. Clinical examination consists in neuropsychological assessment (including mini mental state examination test and Bradley's scale) as well as Hakim's triad evaluation

Locations

Country Name City State
France CHU Amiens Amiens Picardie

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire, Amiens

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary CSF stroke volume Measurement of CSF stroke volume via flow MRI at the Sylvius' aqueduct level Day 1 No
Secondary Hakim's triad evaluation Assessment of the signs of normal pressure hydrocephalus Day 1 No
Secondary Hakim's triad evaluation Assessment of the signs of normal pressure hydrocephalus (follow-up) Day 90 No
Secondary Hakim's triad evaluation Assessment of the signs of normal pressure hydrocephalus (follow-up) Day 365 No
Secondary Neuropsychological test classical neuropsychological assessment (including mini mental status evaluation) Day 1 No
Secondary Neuropsychological test classical neuropsychological assessment (including mini mental status evaluation) (follow up) Day 90 No
Secondary Neuropsychological test classical neuropsychological assessment (including mini mental status evaluation) (follow up) Day 365 No
Secondary CSF stroke volume Measurement of CSF stroke volume by flow MRI at the Sylvius' aqueduct level (follow-up) Day 60 No
Secondary CSF stroke volume Measurement of CSF stroke volume by flow MRI at the Sylvius' aqueduct level (follow-up) Day 365 No
See also
  Status Clinical Trial Phase
Terminated NCT00149721 - Anterior Pituitary Function in Patients With Hydrocephalus N/A
Completed NCT00196196 - A Precision and Accuracy Study of the Codman Valve Position Verification (VPV) System. Phase 3
Not yet recruiting NCT05562596 - Normal Pressure Hydrocephalus Biomarkers Investigation
Unknown status NCT00874198 - European Study on Prediction of Outcome in Patients With Idiopathic Normal Pressure Hydrocephalus N/A
Completed NCT00233701 - Normal Pressure Hydrocephalus (NPH) Registry Phase 4
Withdrawn NCT00793416 - ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients Phase 4
Recruiting NCT05910944 - European Study of Prodromal iNPH
Active, not recruiting NCT01909960 - Flow MRI in Normal Pressure Hydrocephalus N/A
Completed NCT02016352 - Cerebrospinal Fluid Proteome in Hydrocephalus N/A
Terminated NCT01092546 - Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus Phase 3
Terminated NCT00613886 - Factors Predicting Response to Shunting in Normal Pressure Hydrocephalus N/A
Recruiting NCT03877107 - Effect of Depletive Lumbar Puncture on Lower Urinary Tract Dysfunction in iNPH N/A
Enrolling by invitation NCT03269201 - Brain Network Activation in Patients With Movement Disorders
Recruiting NCT03245138 - Endoscopic Third Ventriculostomy Versus Ventriculo-peritoneal Shunting in Idiopathic Normal Pressure Hydrocephalus N/A
Terminated NCT00727142 - Conservative Versus Surgical Management of Idiopathic Normal Pressure Hydrocephalus (INPH) N/A
Recruiting NCT04471740 - Normal Pressure Hydrocephalus and Sleep Apnea N/A
Completed NCT01798641 - A Randomized Cross-over Study for Normal Pressure Hydrocephalus N/A
Recruiting NCT01618500 - Computerised Testing of Cognitive Response to Cerebrospinal Fluid Shunting in Idiopathic Normal Pressure Hydrocephalus N/A
Completed NCT00600795 - Prognostic Value of Transforming Growth Factor-Beta 1 in Normal Pressure Hydrocephalus N/A
Terminated NCT03521518 - CPT-3 in Normal Pressure Hydrocephalus